The global rhinitis market is witnessing steady growth, fueled by increased awareness about respiratory health and innovative treatment options. The introduction of novel intranasal corticosteroids, ...
STMC-103H exhibited 64% reduction in the risk of atopic dermatitis in subjects who completed one year of treatment with strong and consistent effects ...
The Phase 2 study is designed to address regulatory approval considerations by comparing bioavailability and pharmacokinetics ...
The Phase 2 study is designed to address regulatory approval considerations by comparing bioavailability and pharmacokinetics of NS002 against EpiPen Previous clinical study demonstrated NS002 can ach ...
Colds don’t respond to antibiotics, and most over-the-counter medications deliver modest results at best. In recent years, ...
The risk for new-onset respiratory conditions was significantly raised among veterans deployed to Iraq and Afghanistan, ...
My primary care doctor has prescribed the medication Evenity for my osteoporosis. I have been on Fosamax for about three years, but my recent bone density scan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback